gd2 solidphase elisa (Solid Phase Inc)
90
Structured Review
Solid Phase Inc
gd2 solidphase elisa
Gd2 Solidphase Elisa, supplied by Solid Phase Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gd2+solidphase+elisa/gd2+solidphase+elisa/pm23591980-192-16-17
Average 90 stars, based on 1 article reviews
Gd2 Solidphase Elisa, supplied by Solid Phase Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gd2+solidphase+elisa/gd2+solidphase+elisa/pm23591980-192-16-17
Average 90 stars, based on 1 article reviews
gd2 solidphase elisa - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Enzyme-linked Immunosorbent Assay:Article Title: Vaccination with anti-idiotype antibody ganglidiomab mediates a GD(2)-specific anti-neuroblastoma immune response. Article Snippet: Purpose Immunotherapy targeting disialoganglioside GD2 emerges as an important treatment option for neuroblastoma, a pediatric malignancy characterized by poor outcome.. Here, we report the induction of a GD2-specific immune response with ganglidiomab, a new anti-idiotype antibody to anti-GD2 antibodies of the 14.18 family.. Experimental design and results Ganglidiomab was generated following immunization of Balb/c mice with 14G2a, and splenocytes were harvested to generate hybridoma cells. Adjuvant:Article Title: Vaccination with anti-idiotype antibody ganglidiomab mediates a GD(2)-specific anti-neuroblastoma immune response. Article Snippet: Purpose Immunotherapy targeting disialoganglioside GD2 emerges as an important treatment option for neuroblastoma, a pediatric malignancy characterized by poor outcome.. Here, we report the induction of a GD2-specific immune response with ganglidiomab, a new anti-idiotype antibody to anti-GD2 antibodies of the 14.18 family.. Experimental design and results Ganglidiomab was generated following immunization of Balb/c mice with 14G2a, and splenocytes were harvested to generate hybridoma cells. |